Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary.

[1]  P. Calverley,et al.  Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease , 2003, European Respiratory Journal.

[2]  R. Pauwels,et al.  Spirometry in primary care: is it good enough to face demands like World COPD Day? , 2003, European Respiratory Journal.

[3]  N. Chavannes,et al.  Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD) , 2003, Thorax.

[4]  B. Rowe,et al.  Methylxanthines for exacerbations of chronic obstructive pulmonary disease: meta-analysis of randomised trials , 2003, BMJ : British Medical Journal.

[5]  R. Stockley,et al.  Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis , 2003, Thorax.

[6]  S. Spencer,et al.  Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study , 2003, Thorax.

[7]  S. Spencer,et al.  Bronchodilator reversibility testing in chronic obstructive pulmonary disease , 2003, Thorax.

[8]  I. Stiell,et al.  Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. , 2003, The New England journal of medicine.

[9]  J. Wedzicha,et al.  COPD exacerbations: definitions and classifications , 2003, European Respiratory Journal.

[10]  K. N. Maranetra,et al.  Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients. , 2003, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[11]  Steven Piantadosi,et al.  A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. , 2003, The New England journal of medicine.

[12]  Onchee Yu,et al.  Effectiveness of pneumococcal polysaccharide vaccine in older adults. , 2003, The New England journal of medicine.

[13]  Kathleen Kreiss,et al.  American Thoracic Society Statement: Occupational contribution to the burden of airway disease. , 2003, American journal of respiratory and critical care medicine.

[14]  R. Pauwels,et al.  Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial , 2003, The Lancet.

[15]  X. Busquets,et al.  Systemic effects of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[16]  P. Jones,et al.  Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations , 2003, European Respiratory Journal.

[17]  Andrew J. White,et al.  Chronic obstructive pulmonary disease • 6: The aetiology of exacerbations of chronic obstructive pulmonary disease , 2003, Thorax.

[18]  R. Sansores,et al.  Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[19]  J. Alonso,et al.  Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients , 2003, European Respiratory Journal.

[20]  M. Greenstone,et al.  Doxapram for ventilatory failure due to exacerbations of chronic obstructive pulmonary disease. , 2002, The Cochrane database of systematic reviews.

[21]  N. Hanania,et al.  The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD. , 2003, Chest.

[22]  S. Borg,et al.  Costs of COPD in Sweden according to disease severity. , 2007, Chest.

[23]  T. Seemungal,et al.  Chlamydia pneumoniae and COPD exacerbation. , 2002, Thorax.

[24]  J. van der Palen,et al.  Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study. , 2002, American journal of respiratory and critical care medicine.

[25]  A. Buist,et al.  Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers , 2002, European Respiratory Journal.

[26]  D Olivieri,et al.  Efficacy and safety of oxitropium bromide, theophylline and their combination in COPD patients: a double-blind, randomized, multicentre study (BREATH Trial). , 2002, Respiratory medicine.

[27]  J. Higgins,et al.  A systematic review of the use of opioids in the management of dyspnoea , 2002, Thorax.

[28]  G. Marks,et al.  Primary care Randomised controlled trial of home based care of patients with chronic obstructive pulmonary disease , 2022 .

[29]  Surinder S Birring,et al.  Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers: a descriptive study. , 2002, American journal of respiratory and critical care medicine.

[30]  J. Yates,et al.  Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.

[31]  D. Postma,et al.  Chronic obstructive pulmonary disease. , 2002, Clinical evidence.

[32]  M. Antonelli,et al.  Noninvasive vs. conventional mechanical ventilation in patients with chronic obstructive pulmonary disease after failure of medical treatment in the ward: a randomized trial , 2002, Intensive Care Medicine.

[33]  B. Grant,et al.  New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. , 2002, The New England journal of medicine.

[34]  D. Mannino,et al.  Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. , 2002, Morbidity and mortality weekly report. Surveillance summaries.

[35]  F. Blasi,et al.  Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment , 2002, Thorax.

[36]  Edwin K Silverman,et al.  Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease. , 2002, American journal of human genetics.

[37]  A. Schols,et al.  Systemic effects in COPD. , 2002, Chest.

[38]  A. Diacon,et al.  Functional evaluation before lung resection. , 2002, Clinics in chest medicine.

[39]  F. Maltais,et al.  Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. , 2002, American journal of respiratory and critical care medicine.

[40]  J. V. van Noord,et al.  Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium , 2002, European Respiratory Journal.

[41]  Alyn H. Morice,et al.  Patients' and carers' preferences in two models of care for acute exacerbations of COPD: results of a randomised controlled trial , 2002, Thorax.

[42]  Salvador Benito,et al.  Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study. , 2002, JAMA.

[43]  T. Seemungal,et al.  Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[44]  R. Dahl,et al.  Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[45]  M. Elliott,et al.  Non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: long term survival and predictors of in-hospital outcome , 2001, Thorax.

[46]  William C. Cockerham.  Physicians , 2001, BMJ : British Medical Journal.

[47]  R. Zuwallack,et al.  Salmeterol plus theophylline combination therapy in the treatment of COPD. , 2001, Chest.

[48]  P. Anderson,et al.  Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial , 2001, The Lancet.

[49]  I. Weisman.  Cardiopulmonary exercise testing in the preoperative assessment for lung resection surgery. , 2001, Seminars in thoracic and cardiovascular surgery.

[50]  J. Connett,et al.  Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.

[51]  E. Silverman,et al.  Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[52]  B. Grant,et al.  Airway inflammation and etiology of acute exacerbations of chronic bronchitis. , 2000, Chest.

[53]  R M Angus,et al.  “Hospital at home” versus hospital care in patients with exacerbations of chronic obstructive pulmonary disease: prospective randomised controlled trial , 2000, BMJ : British Medical Journal.

[54]  C. Bucknall,et al.  Early discharge for patients with exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial , 2000, Thorax.

[55]  N. Pride,et al.  Recent trends in physician diagnosed COPD in women and men in the UK , 2000, Thorax.

[56]  L. Stead,et al.  Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library , 2000, BMJ : British Medical Journal.

[57]  P. Plant,et al.  Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial , 2000, The Lancet.

[58]  Michael C. Fiore,et al.  A Clinical Practice Guideline for Treating Tobacco Use and Dependence A US Public Health Service Report , 2000 .

[59]  S. Spencer,et al.  Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial , 2000, BMJ : British Medical Journal.

[60]  M J Tobin,et al.  How is mechanical ventilation employed in the intensive care unit? An international utilization review. , 2000, American journal of respiratory and critical care medicine.

[61]  W. Hop,et al.  Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium. , 2000, The European respiratory journal.

[62]  T. Seemungal,et al.  Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[63]  R. Rodríguez-Roisín,et al.  Toward a consensus definition for COPD exacerbations. , 2000, Chest.

[64]  N. Payne,et al.  Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial , 2000, The Lancet.

[65]  W. MacNee,et al.  Randomized controlled trial of supported discharge in patients with exacerbations of chronic obstructive pulmonary disease. , 2000, Thorax.

[66]  A. Adelman.  Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. , 1999, The Journal of family practice.

[67]  N. Adair,et al.  Exercise rehabilitation and chronic obstructive pulmonary disease stage. , 1999, American journal of respiratory and critical care medicine.

[68]  L. Davies,et al.  Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial , 1999, The Lancet.

[69]  J. Garrett,et al.  Spirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshops. , 1999, Chest.

[70]  D. Niewoehner,et al.  Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. , 1999, The New England journal of medicine.

[71]  P. Lange,et al.  Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial , 1999, The Lancet.

[72]  J. Vestbo,et al.  Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study. , 1999, The European respiratory journal.

[73]  P. Tousignant,et al.  The health and cost effects of substituting home care for inpatient acute care: a review of the evidence. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[74]  S. Yancey,et al.  Efficacy of salmeterol xinafoate in the treatment of COPD. , 1999, Chest.

[75]  Aker,et al.  A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. , 1999, The New England journal of medicine.

[76]  P. Young,et al.  Improvements in outcomes for chronic obstructive pulmonary disease (COPD) attributable to a hospital-based respiratory rehabilitation programme. , 1999, Australian and New Zealand journal of medicine.

[77]  D. Hess,et al.  Noninvasive positive pressure ventilation for acute respiratory failure. , 1999, International anesthesiology clinics.

[78]  J. Britton,et al.  Helping people to stop smoking: the new smoking cessation guidelines , 1999, Thorax.

[79]  A. Laupacis,et al.  Theophylline for irreversible chronic airflow limitation: a randomized study comparing n of 1 trials to standard practice. , 1999, Chest.

[80]  N. Ambrosino,et al.  Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction. , 1999, The European respiratory journal.

[81]  D. Postma,et al.  Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. , 1999, The New England journal of medicine.

[82]  E. Weitzenblum,et al.  Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[83]  M. Shulman,et al.  Preoperative pulmonary evaluation. , 1999 .

[84]  Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation--a consensus conference report. , 1999, Chest.

[85]  R. Phillips,et al.  A comparison of generalist and pulmonologist care for patients hospitalized with severe chronic obstructive pulmonary disease: resource intensity, hospital costs, and survival. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. , 1998, The American journal of medicine.

[86]  N. Gross,et al.  Inhalation by Nebulization of Albuterol-Ipratropium Combination (Dey Combination) Is Superior to Either Agent Alone in the Treatment of Chronic Obstructive Pulmonary Disease , 1998, Respiration.

[87]  J. Stoller,et al.  Inpatient management of chronic obstructive pulmonary disease. , 1998, Respiratory care clinics of North America.

[88]  L. Boulet,et al.  Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians. , 1998, Chest.

[89]  International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[90]  J. Gravil,et al.  Home treatment of exacerbations of chronic obstructive pulmonary disease by an acute respiratory assessment service , 1998, The Lancet.

[91]  S. Shepperd,et al.  Randomised controlled trial comparing hospital at home care with inpatient hospital care. II: cost minimisation analysis. , 1998, BMJ.

[92]  P. Poole,et al.  The effect of sustained-release morphine on breathlessness and quality of life in severe chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[93]  J. Wlodarczyk,et al.  Severe exacerbation of chronic obstructive airways disease: health resource use in general practice and hospital. , 1998, Journal of quality in clinical practice.

[94]  D. Gruson,et al.  Noninvasive pressure support ventilation in COPD patients with postextubation hypercapnic respiratory insufficiency. , 1998, The European respiratory journal.

[95]  C. Sanguinetti,et al.  Airways microbial flora in COPD patients in stable clinical conditions and during exacerbations: a bronchoscopic investigation. , 1998, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[96]  W. Stalman,et al.  Is immunising all patients with chronic lung disease in the community against influenza cost effective? Evidence from a general practice based clinical prospective cohort study in Utrecht, The Netherlands. , 1998, Journal of epidemiology and community health.

[97]  R. Novick,et al.  Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease , 1998, The Lancet.

[98]  R. Novick,et al.  The Registry of the International Society for Heart and Lung Transplantation: fifteenth official report--1998. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[99]  C. Bolliger,et al.  Functional evaluation of the lung resection candidate. , 1998, The European respiratory journal.

[100]  J. Collet,et al.  Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant. , 1997, American journal of respiratory and critical care medicine.

[101]  D. Harrison,et al.  Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema , 1997, The Lancet.

[102]  A. Jones,et al.  NO: COPD and beyond , 1997, Thorax.

[103]  Alan D. Lopez,et al.  Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.

[104]  R. Breiman,et al.  Prevention of pneumococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP) , 1997 .

[105]  J. Heffner,et al.  Outcomes of advance directive education of pulmonary rehabilitation patients. , 1997, American journal of respiratory and critical care medicine.

[106]  U Ackermann-Liebrich,et al.  Lung function and long term exposure to air pollutants in Switzerland. Study on Air Pollution and Lung Diseases in Adults (SAPALDIA) Team. , 1997, American journal of respiratory and critical care medicine.

[107]  A. Buist,et al.  Routine nebulized ipratropium and albuterol together are better than either alone in COPD. The COMBIVENT Inhalation Solution Study Group. , 1997, Chest.

[108]  N. Anthonisen.  OM-8BV for COPD. , 1997, American journal of respiratory and critical care medicine.

[109]  Ose,et al.  A COMPARISON OF FOUR METHODS OF WEANING PATIENTS FROM MECHANICAL VENTILATION , 1997 .

[110]  L Goldman,et al.  Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) , 1996, American journal of respiratory and critical care medicine.

[111]  J. Crowley,et al.  Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. , 1996, American journal of respiratory and critical care medicine.

[112]  M. Decramer,et al.  Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.

[113]  C. van Weel,et al.  Prevalence of asthma and COPD in general practice in 1992: has it changed since 1977? , 1996, The British journal of general practice : the journal of the Royal College of General Practitioners.

[114]  J. Barberà,et al.  Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease , 1996, The Lancet.

[115]  Calverley Pm.  Neuropsychological deficits in chronic obstructive pulmonary disease. , 1996 .

[116]  Neuropsychological deficits in chronic obstructive pulmonary disease. , 1996, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[117]  L. Allegra,et al.  Prevention of acute exacerbations of chronic obstructive bronchitis with carbocysteine lysine salt monohydrate: a multicenter, double-blind, placebo-controlled trial. , 1996, Respiration; international review of thoracic diseases.

[118]  Alan D. Lopez,et al.  The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020. , 1996 .

[119]  J. Deslauriers,et al.  Indications for surgery and patient work-up for bullectomy. , 1995, Chest surgery clinics of North America.

[120]  R. Mellins,et al.  Physician‐patient partnership in managing chronic illness , 1995, Academic medicine : journal of the Association of American Medical Colleges.

[121]  J. Ruiz,et al.  Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. , 1995, American journal of respiratory and critical care medicine.

[122]  M. Wysocki,et al.  Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. , 1995, The New England journal of medicine.

[123]  B. Celli,et al.  Long-term oxygen therapy. , 1995, The New England journal of medicine.

[124]  B. Celli.  Pulmonary rehabilitation in patients with COPD. , 1995, American journal of respiratory and critical care medicine.

[125]  I. Tager,et al.  Maternal smoking during pregnancy. Effects on lung function during the first 18 months of life. , 1995, American journal of respiratory and critical care medicine.

[126]  J C Yernault,et al.  Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. , 1995, The European respiratory journal.

[127]  N. Hill,et al.  Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure. , 1995, American journal of respiratory and critical care medicine.

[128]  M. Stewart.  Effective physician-patient communication and health outcomes: a review. , 1995, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[129]  K. Nishimura,et al.  Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone. , 1995, Chest.

[130]  A. Esteban,et al.  A comparison of four methods of weaning patients from mechanical ventilation. Spanish Lung Failure Collaborative Group. , 1995, The New England journal of medicine.

[131]  W. Bailey,et al.  Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. , 1995, JAMA.

[132]  D. Postma,et al.  Quality of Life in Patients With Chronic Obstructive Pulmonary Disease Improves After Rehabilitation at Home , 1995 .

[133]  G. Guyatt,et al.  Randomised controlled trial of respiratory rehabilitation , 1994, The Lancet.

[134]  U. Ackermann-Liebrich,et al.  Passive smoking exposure in adults and chronic respiratory symptoms (SAPALDIA Study). Swiss Study on Air Pollution and Lung Diseases in Adults, SAPALDIA Team. , 1994, American journal of respiratory and critical care medicine.

[135]  L. Brochard,et al.  Comparison of three methods of gradual withdrawal from ventilatory support during weaning from mechanical ventilation. , 1994, American journal of respiratory and critical care medicine.

[136]  K. Nichol,et al.  The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. , 1994, The New England journal of medicine.

[137]  T. Evald,et al.  Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitis. , 1994, Respiratory medicine.

[138]  M. Decramer,et al.  Corticosteroids contribute to muscle weakness in chronic airflow obstruction. , 1994, American journal of respiratory and critical care medicine.

[139]  J. Schouten,et al.  Smoking, changes in smoking habits, and rate of decline in FEV1: new insight into gender differences. , 1994, The European respiratory journal.

[140]  C. van Weel,et al.  Consultation rates and incidence of intercurrent morbidity among patients with chronic disease in general practice. , 1994, The British journal of general practice : the journal of the Royal College of General Practitioners.

[141]  R. Sharrar,et al.  Passive smoking in obstructive respiratory disease in an industrialized urban population. , 1994, Environmental research.

[142]  T. Meyer,et al.  Noninvasive Positive Pressure Ventilation To Treat Respiratory Failure , 1994, Annals of Internal Medicine.

[143]  S. Holgate,et al.  The relationship between pneumonia in early childhood and impaired lung function in late adult life. , 1994, American journal of respiratory and critical care medicine.

[144]  W. Dupont,et al.  A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. , 1994, The Journal of infectious diseases.

[145]  K. Chapman,et al.  Physician perceptions and management of COPD. , 1993, Chest.

[146]  J. Wedzicha,et al.  Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease , 1993, The Lancet.

[147]  E. Wouters,et al.  Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. , 1993, The American review of respiratory disease.

[148]  Shun-zhang Yu,et al.  Priority among air pollution factors for preventing chronic obstructive pulmonary disease in Shanghai. , 1992, The Science of the total environment.

[149]  M. Decramer,et al.  Corticosteroid-induced myopathy involving respiratory muscles in patients with chronic obstructive pulmonary disease or asthma. , 1992, The American review of respiratory disease.

[150]  B. O'driscoll,et al.  A long-term prospective assessment of home nebulizer treatment. , 1992, Respiratory medicine.

[151]  J. Barberà,et al.  Effect of intravenously administered aminophylline on ventilation/perfusion inequality during recovery from exacerbations of chronic obstructive pulmonary disease. , 1992, The American review of respiratory disease.

[152]  K. Godfrey,et al.  Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. , 1991, BMJ.

[153]  N. Eiser,et al.  Oral diamorphine: lack of effect on dyspnoea and exercise tolerance in the "pink puffer" syndrome. , 1991, The European respiratory journal.

[154]  A I Mushlin,et al.  The necessary length of hospital stay for chronic pulmonary disease. , 1991, JAMA.

[155]  Y. Scherer,et al.  Can a Pulmonary Health Teaching Program Alter Patients’ Ability to Cope with COPD? , 1991, Rehabilitation nursing : the official journal of the Association of Rehabilitation Nurses.

[156]  A. Tattersfield,et al.  Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis. , 1991, The European respiratory journal.

[157]  D. Georgopoulos.  Symptoms and signs of COPD , 1991 .

[158]  Husten Cg,et al.  How to help your patients stop smoking. , 1990 .

[159]  A. Connors,et al.  Theophylline concentrations in patients with acute exacerbation of COPD. , 1990, The American journal of emergency medicine.

[160]  M. Wakefield,et al.  “Sick of Smoking”: evaluation of a targeted minimal smoking cessation intervention in general practice , 1990, The Medical journal of Australia.

[161]  J. Theodore,et al.  Lung transplantation comes of age. , 1990, The New England journal of medicine.

[162]  T. Pechacek,et al.  Physician-initiated smoking cessation program: the National Cancer Institute trials. , 1990, Progress in clinical and biological research.

[163]  T. Petty.  The National Mucolytic Study. Results of a randomized, double-blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis. , 1990, Chest.

[164]  R. Kaplan,et al.  Experimental evaluation of rehabilitation in chronic obstructive pulmonary disease: short-term effects on exercise endurance and health status. , 1990, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[165]  C. Shim.  Response to bronchodilators. , 1989, Clinics in chest medicine.

[166]  A. Connors,et al.  Relationship between arterial blood gases and spirometry in acute exacerbations of chronic obstructive pulmonary disease. , 1989, Annals of emergency medicine.

[167]  T. Petty,et al.  Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study. , 1989, The American review of respiratory disease.

[168]  E. Daviskas,et al.  Effect of low dose nebulised morphine on exercise endurance in patients with chronic lung disease. , 1989, Thorax.

[169]  H. Chrystyn,et al.  Dose response relation to oral theophylline in severe chronic obstructive airways disease. , 1988, BMJ.

[170]  J. Britton,et al.  High-dose inhaled albuterol in severe chronic airflow limitation. , 1988, The American review of respiratory disease.

[171]  F. Speizer,et al.  The natural history of forced expiratory volumes. Effect of cigarette smoking and respiratory symptoms. , 1988, The American review of respiratory disease.

[172]  J. Montserrat,et al.  Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease. , 1988, The European respiratory journal.

[173]  M. Ardawi,et al.  Effects of sheesha and cigarette smoking on pulmonary function of Saudi males and females. , 1988, Tropical and geographical medicine.

[174]  J. B. Rasmussen,et al.  Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis. , 1988, The European respiratory journal.

[175]  G. Guyatt,et al.  A controlled trial of ambroxol in chronic bronchitis. , 1987, Chest.

[176]  G. Guyatt,et al.  A measure of quality of life for clinical trials in chronic lung disease. , 1987, Thorax.

[177]  J. Moxham,et al.  Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation. , 1987, Chest.

[178]  H. D. Short,et al.  Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life. , 1987, The American review of respiratory disease.

[179]  P. Holt.  Immune and inflammatory function in cigarette smokers. , 1987, Thorax.

[180]  N. Anthonisen,et al.  Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. , 1987, Annals of internal medicine.

[181]  Phillips Yy,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. , 1987, The American review of respiratory disease.

[182]  D. Niewoehner,et al.  Effects of chronic administration of codeine and promethazine on breathlessness and exercise tolerance in patients with chronic airflow obstruction. , 1987, British journal of diseases of the chest.

[183]  N. Anthonisen,et al.  Alteration in breathing pattern with progression of chronic obstructive pulmonary disease. , 2015, The American review of respiratory disease.

[184]  Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction. British Thoracic Society Research Committee. , 1985, Thorax.

[185]  D. Taylor,et al.  The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction. , 1985, The American review of respiratory disease.

[186]  M. Aubier,et al.  Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease. , 1984, The New England journal of medicine.

[187]  G. Boman,et al.  Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases. , 1983, European journal of respiratory diseases.

[188]  A. Woodcock,et al.  Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases. , 1981, The New England journal of medicine.

[189]  M. Pathy,et al.  Follow-up study of disability among elderly patients discharged from hospital with exacerbations of chronic bronchitis. , 1981, Thorax.

[190]  Cotes Je,et al.  LONG TERM DOMICILIARY OXYGEN THERAPY IN CHRONIC HYPOXIC COR PULMONALE COMPLICATING CHRONIC BRONCHITIS AND EMPHYSEMA Report of the Medical Research Council Working Party , 1981, The Lancet.

[191]  P. Vacek,et al.  Evaluation of a community-based education program for individuals with chronic obstructive pulmonary disease. , 1980, Journal of rehabilitation.

[192]  D. Flenley,et al.  RESPIRATORY FAILURE REVISITED: ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS BETWEEN 1961-68 AND 1970-76 , 1980, The Lancet.

[193]  S. P. Gupta,et al.  Physical rehabilitation for the chronic bronchitic: results of a controlled trial of exercises in the home. , 1977, Thorax.

[194]  D. Smith,et al.  Five-year winter chemoprophylaxis for chronic bronchitis , 1969, British medical journal.

[195]  H. C. Couch.  Value of chemoprophylaxis and chemotherapy in early chronic bronchitis. A report to the Medical Research Council by their working party on trials of chemotherapy in early chronic bronchitis. , 1966, British medical journal.